Today in healthcare news: Meet the startup connecting people to leftover vaccines, Hims faces a class action lawsuit over alleged spam texts, and what the US looked like a year ago before we took masks and social distancing seriously.
A new website will connect people with leftover COVID-19 vaccines by sending texts when a shot is going spare
- Allocating excess doses has been a challenge in the COVID-19 vaccine rollout.
- Dr. B, a triaged vaccine-standby list, could help get those doses to high-priority recipients.
- The team behind Dr. B is trying to reach vulnerable groups through community partnerships.
- Digital health company Hims became the subject of a class-action lawsuit filed in California on Tuesday.
- The complaint alleges Hims violated the Telephone Consumer Protection Act with a series of alleged spam text messages.
- The suit was brought by David Vaccaro, a California resident who maintains he was not a Hims patient when he began receiving programmed voice and text messages from the company.
- A year ago, public-health officials didn’t fully understand how the coronavirus spreads.
- Masks weren’t yet recommended.
- Photos show people blowing their noses in public, meeting at bars, and attending basketball games.
More stories we’re reading:
- US coronavirus vaccinations have surpassed the country’s number of known COVID-19 cases (Insider)
- Adaptive’s FDA-authorized T-cell test, which could be a big help for long-haulers who haven’t gotten a clear answer if they’ve been infected (ABC News)
- CDC: People with a very high or a very low BMI have a much higher risk of severe COVID-19 (Insider)
- America’s vaccine system is making people with preexisting conditions fight for shots (The New York Times)
- Cedar just raised a $US200 ($260) million Series D at a $US3.2 ($4) billion valuation. Here’s a look at the pitch deck it used to raise its Series C. (Insider)